Contact
Please use this form to send email to PR contact of this press release:
Orphan designation: Upifitamab rilsodotin Treatment of ovarian cancer, 09/12/2022 Positive
TO:
Please use this form to send email to PR contact of this press release:
Orphan designation: Upifitamab rilsodotin Treatment of ovarian cancer, 09/12/2022 Positive
TO: